603 related articles for article (PubMed ID: 23955151)
41. Structural characterization of M8C10, a neutralizing antibody targeting a highly conserved prefusion-specific epitope on the metapneumovirus fusion trimerization interface.
Xiao X; Wen Z; Chen Q; Shipman JM; Kostas J; Reid JC; Warren C; Tang A; Luo B; O'Donnell G; Fridman A; Chen Z; Vora KA; Zhang L; Su H-P; Eddins MJ
J Virol; 2023 Dec; 97(12):e0105223. PubMed ID: 38032197
[TBL] [Abstract][Full Text] [Related]
42. Chimeric bovine respiratory syncytial virus with glycoprotein gene substitutions from human respiratory syncytial virus (HRSV): effects on host range and evaluation as a live-attenuated HRSV vaccine.
Buchholz UJ; Granzow H; Schuldt K; Whitehead SS; Murphy BR; Collins PL
J Virol; 2000 Feb; 74(3):1187-99. PubMed ID: 10627529
[TBL] [Abstract][Full Text] [Related]
43. Immunology of bovine respiratory syncytial virus in calves.
Guzman E; Taylor G
Mol Immunol; 2015 Jul; 66(1):48-56. PubMed ID: 25553595
[TBL] [Abstract][Full Text] [Related]
44. Aberrant T cell immunity triggered by human Respiratory Syncytial Virus and human Metapneumovirus infection.
González AE; Lay MK; Jara EL; Espinoza JA; Gómez RS; Soto J; Rivera CA; Abarca K; Bueno SM; Riedel CA; Kalergis AM
Virulence; 2017 Aug; 8(6):685-704. PubMed ID: 27911218
[TBL] [Abstract][Full Text] [Related]
45. A Sendai virus recombinant vaccine expressing a gene for truncated human metapneumovirus (hMPV) fusion protein protects cotton rats from hMPV challenge.
Russell CJ; Jones BG; Sealy RE; Surman SL; Mason JN; Hayden RT; Tripp RA; Takimoto T; Hurwitz JL
Virology; 2017 Sep; 509():60-66. PubMed ID: 28605636
[TBL] [Abstract][Full Text] [Related]
46. Induction of Trained Immunity by Recombinant Vaccines.
Covián C; Ríos M; Berríos-Rojas RV; Bueno SM; Kalergis AM
Front Immunol; 2020; 11():611946. PubMed ID: 33584692
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of pre- and post-fusion Human metapneumovirus F proteins as subunit vaccine candidates in mice.
Pilaev M; Shen Y; Carbonneau J; Venable MC; Rhéaume C; Lavigne S; Couture C; Guarné A; Hamelin MÈ; Boivin G
Vaccine; 2020 Feb; 38(9):2122-2127. PubMed ID: 32007293
[TBL] [Abstract][Full Text] [Related]
48. Innate Immune Components that Regulate the Pathogenesis and Resolution of hRSV and hMPV Infections.
Andrade CA; Pacheco GA; Gálvez NMS; Soto JA; Bueno SM; Kalergis AM
Viruses; 2020 Jun; 12(6):. PubMed ID: 32545470
[TBL] [Abstract][Full Text] [Related]
49. Potent Human Single-Domain Antibodies Specific for a Novel Prefusion Epitope of Respiratory Syncytial Virus F Glycoprotein.
Xun G; Song X; Hu J; Zhang H; Liu L; Zhang Z; Gong R
J Virol; 2021 Aug; 95(18):e0048521. PubMed ID: 34160257
[TBL] [Abstract][Full Text] [Related]
50. Seroprevalence of human respiratory syncytial virus and human metapneumovirus in healthy population analyzed by recombinant fusion protein-based enzyme linked immunosorbent assay.
Sastre P; Ruiz T; Schildgen O; Schildgen V; Vela C; Rueda P
Virol J; 2012 Jul; 9():130. PubMed ID: 22748150
[TBL] [Abstract][Full Text] [Related]
51. Respiratory syncytial virus prefusogenic fusion (F) protein nanoparticle vaccine: Structure, antigenic profile, immunogenicity, and protection.
Patel N; Massare MJ; Tian JH; Guebre-Xabier M; Lu H; Zhou H; Maynard E; Scott D; Ellingsworth L; Glenn G; Smith G
Vaccine; 2019 Sep; 37(41):6112-6124. PubMed ID: 31416644
[TBL] [Abstract][Full Text] [Related]
52. The two major human metapneumovirus genetic lineages are highly related antigenically, and the fusion (F) protein is a major contributor to this antigenic relatedness.
Skiadopoulos MH; Biacchesi S; Buchholz UJ; Riggs JM; Surman SR; Amaro-Carambot E; McAuliffe JM; Elkins WR; St Claire M; Collins PL; Murphy BR
J Virol; 2004 Jul; 78(13):6927-37. PubMed ID: 15194769
[TBL] [Abstract][Full Text] [Related]
53. Monoclonal antibody based in vitro potency assay as a predictor of antigenic integrity and in vivo immunogenicity of a Respiratory Syncytial Virus post-fusion F-protein based vaccine.
Djagbare MD; Yu L; Parupudi A; Sun J; Coughlin ML; Rush BS; Sanyal G
Vaccine; 2018 Mar; 36(12):1673-1680. PubMed ID: 29456016
[TBL] [Abstract][Full Text] [Related]
54. Reversion of somatic mutations of the respiratory syncytial virus-specific human monoclonal antibody Fab19 reveal a direct relationship between association rate and neutralizing potency.
Bates JT; Keefer CJ; Utley TJ; Correia BE; Schief WR; Crowe JE
J Immunol; 2013 Apr; 190(7):3732-9. PubMed ID: 23455501
[TBL] [Abstract][Full Text] [Related]
55. Antibody development for preventing the human respiratory syncytial virus pathology.
Soto JA; Gálvez NMS; Pacheco GA; Bueno SM; Kalergis AM
Mol Med; 2020 Apr; 26(1):35. PubMed ID: 32303184
[TBL] [Abstract][Full Text] [Related]
56. Human Metapneumovirus.
Schuster JE; Williams JV
Microbiol Spectr; 2014 Oct; 2(5):. PubMed ID: 26104361
[TBL] [Abstract][Full Text] [Related]
57. Generation of temperature-sensitive human metapneumovirus strains that provide protective immunity in hamsters.
Herfst S; de Graaf M; Schrauwen EJA; Sprong L; Hussain K; van den Hoogen BG; Osterhaus ADME; Fouchier RAM
J Gen Virol; 2008 Jul; 89(Pt 7):1553-1562. PubMed ID: 18559924
[TBL] [Abstract][Full Text] [Related]
58. Structure and immunogenicity of pre-fusion-stabilized human metapneumovirus F glycoprotein.
Battles MB; Más V; Olmedillas E; Cano O; Vázquez M; Rodríguez L; Melero JA; McLellan JS
Nat Commun; 2017 Nov; 8(1):1528. PubMed ID: 29142300
[TBL] [Abstract][Full Text] [Related]
59. Characterization of Pre-F-GCN4t, a Modified Human Respiratory Syncytial Virus Fusion Protein Stabilized in a Noncleaved Prefusion Conformation.
Blais N; Gagné M; Hamuro Y; Rheault P; Boyer M; Steff AM; Baudoux G; Dewar V; Demers J; Ruelle JL; Martin D
J Virol; 2017 Jul; 91(13):. PubMed ID: 28404847
[TBL] [Abstract][Full Text] [Related]
60. Structural basis for recognition of the central conserved region of RSV G by neutralizing human antibodies.
Jones HG; Ritschel T; Pascual G; Brakenhoff JPJ; Keogh E; Furmanova-Hollenstein P; Lanckacker E; Wadia JS; Gilman MSA; Williamson RA; Roymans D; van 't Wout AB; Langedijk JP; McLellan JS
PLoS Pathog; 2018 Mar; 14(3):e1006935. PubMed ID: 29509814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
